Compositions and methods for use for antibodies against sclerostin

Details for Australian Patent Application No. 2008309514 (hide)

Owner Novartis AG

Inventors Hu, Shou-Ih; Halleux, Christine; Kneissel, Michaela; DiefenbachStreiber, Beate; Prassler, Josef

Agent Davies Collison Cave

Pub. Number AU-B-2008309514

PCT Pub. Number WO2009/047356

Priority 08151911.8 25.02.08 EP; 08161342.4 29.07.08 EP; 07118414.7 12.10.07 EP

Filing date 10 October 2008

Wipo publication date 16 April 2009

Acceptance publication date 23 June 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61P 19/10 (2006.01) Drugs for skeletal disorders

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/047356 Priority application(s): WO2009/047356

23 June 2011 Application Accepted

  Published as AU-B-2008309514

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008309517-Inhibitors of protein kinases

2008309510-Bone fixing system and method of use